Trasylol-Aprotinin, an injectable drug produced by the huge
German pharmaceutical conglomerate Bayer AG, is normally
used to control bleeding after heart bypass surgery and
other heart-related procedures.
But the drug, which is used in 60 percent of all bypass
procedures, actually contributes to decreased health in
bypass patients by doubling heart bypass patients' risk of
developing dialysis-demanding kidney failure, in addition
to increasing the possibility of future strokes, heart
attacks, and even death.
In fact, it is estimated that use of the Trasylol-Aprotinin
injection causes 10,000 cases of kidney failure in heart
bypass patients every year.
Other Staggering Statistics
10,000 is a huge number...but what about 109 or even 181
percent? These are the percentages by which Trasylol
patients are at risk for heart failure and stroke,
respectively.
In addition, Trasylol has been proven to make bypass
surgery patients twice as likely to suffer kidney failure.
This will lead to hundreds of millions of dollars in
healthcare costs - a number that stands in stark contrast
to Bayer's December 2005 announcement that the drug had a
$615 million sales potential.
And the statistics don't stop there - a January 2006 study
by researchers at the Ischemic Research and Education
Foundation in California stated that switching to generic
Trasylol alternatives, such as tranexamic acid or
aminocaproic acid, could not only prevent over 11,000
kidney complications a year, but could also reduce
worldwide drug costs by over $200 million and save over a
billion healthcare dollars. Serious statistics for a drug
that has been given rise to serious medical concerns.
Bayer Continues to Market and Promote
As recently as March 2006, Bayer AG continued to vehemently
defend and market its potentially dangerous drug, Trasylol.
It is currently pushing to have the drug approved for use
in hip replacement surgeries, thus widening the drug's
potential market - and exposing an ever larger market to
its dangerous side effects.
Though the drug costs 10 times more than its generic
counterparts (which have not been proven to provoke any
dangerous renal or heart symptoms), Bayer AG continues to
promote and sell it to over 1 million bypass and other
heart surgery patients per year.
If You Have Experienced Side Effects
If you have experienced negative side effects due to your
use of injectable Trasylol-Aprotinin, including but not
limited to encephalopathy, renal failure, heart problems,
or stroke, contact an experienced pharmaceutical products
attorney after seeking competent medical care.
Your Trasylol lawyer can assess your potential case, help
you file your lawsuit, and even help you gain monetary
compensation for your medical bills, lost wages, future
medical care and pain and suffering due to the dangerous
side effects of Trasylol-Aprotinin.
Patients who have undergone extreme heart-related surgical
procedures like heart bypass surgery do not deserve to
continue the suffering that can be related to
Trasylol-Aprotinin's dangerous side effects.
----------------------------------------------------
LegalView.com, your source for everything legal on the web
is your complete legal information portal. Visit us at
http://www.legalview.com/ for information on contacting a
Trasylol lawyer, or a Vytorin Attorney. Users can also go
to http://duragesic.legalview.com to contact a Duragesic
patch law firm in their area, with pharmaceutical lawsuit
experience.
No comments:
Post a Comment